Sygen Pharmaceuticals secures investment from Àrgentil Capital and other co-investors

NIGERIA – Àrgentil Capital Management Limited, a boutique investment banking firm, has announced its equity investment in Sygen Pharmaceuticals Limited that was structured via the sponsors’ investment vehicle, Consumer Growth Partners along with other co-investors. Àrgentil invested in the transaction based on the management teams strong track record in excess of 155 years’ leading and managing operations of FMCG companies…

Read More